newsfilter
← Latest News
GlobeNewswire·

Chemomab Therapeutics to Report Third Quarter 2024 Financial Results and Provide a Business Update

TEL AVIV, Israel, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Chemomab Therapeutics Ltd. (NASDAQ:CMMB) ("Chemomab" or the "Company"), a clinical stage biotechnology company developing innovative therapeutics for